CSIMarket
 


Intelligent Bio Solutions Inc   (INBS)
Other Ticker:  
 
 

INBS's Revenue Growth by Quarter and Year

Intelligent Bio Solutions Inc 's Revenue results by quarter and year




INBS Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter June - 0.07 0.00 0.00
III Quarter March - 0.19 0.00 0.00
II Quarter December 0.36 0.18 0.00 0.00
I Quarter September 0.31 0.00 0.00 0.00
FY   0.67 0.44 0.00 0.00



INBS Revenue second quarter 2023 Y/Y Growth Comment
Intelligent Bio Solutions Inc reported Revenue surge of 98.16% year on year in the second quarter 2023, to $ 0.36 millions, this is lower than Intelligent Bio Solutions Inc 's recent average Revenue surge of 100.62%.

Looking into second quarter 2023 results within Medical Equipment & Supplies industry 6 other companies have achieved higher Revenue growth. While Intelligent Bio Solutions Inc ' s Revenue jump of 98.16% ranks overall at the positon no. 157 in the second quarter 2023.




INBS Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December 98.16 % - - -
I Quarter September - - - -
FY   - - - -

Financial Statements
Intelligent Bio Solutions Inc 's second quarter 2023 Revenue $ 0.36 millions INBS's Income Statement
Intelligent Bio Solutions Inc 's second quarter 2022 Revenue $ 0.18 millions Quarterly INBS's Income Statement
New: More INBS's historic Revenue Growth >>


INBS Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter June - -63.16 % - -
III Quarter March - 5.56 % - -
II Quarter December 15.06 % - - -
I Quarter September 342.86 % - - -
FY (Year on Year)   - - - -




Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #7
Healthcare Sector #50
Overall #157

Revenue Y/Y Growth Statistics
High Average Low
100.62 % 100.62 % 100.62 %
(Dec 31 2022)  
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #7
Healthcare Sector #50
Overall #157
Revenue Y/Y Growth Statistics
High Average Low
100.62 % 100.62 % 100.62 %
(Dec 31 2022)  

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Intelligent Bio Solutions Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
365.66 % 80.81 % -65.27 %
(Sep 30 2022)  


INBS's II. Quarter Q/Q Revenue Comment
Intelligent Bio Solutions Inc achieved in the II. Quarter 2023 below company average Revenue jump of 15.06% quarter on quarter, to $ 0.36 millions.

Even if the II. Quarter 2023 Intelligent Bio Solutions Inc 's performance was lower than the regular of 80.81 %, it was yet good sign, as the II. Quarter expension, outshines the % rise in the same quarter a year ago

Within Medical Equipment & Supplies industry 15 other companies have achieved higher Revenue quarter on quarter growth. While Intelligent Bio Solutions Inc 's Revenue growth quarter on quarter, overall rank is 351.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #16
Healthcare Sector #82
Overall #351
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #16
Healthcare Sector #82
Overall #351
Revenue Q/Q Growth Statistics
High Average Low
365.66 % 80.81 % -65.27 %
(Sep 30 2022)  


INBS's II. Quarter Q/Q Revenue Comment
Intelligent Bio Solutions Inc achieved in the II. Quarter 2023 below company average Revenue jump of 15.06% quarter on quarter, to $ 0.36 millions.

Although the II. Quarter 2023 performance was beneath the regular of 80.81 %, this was yet good news, as the II. Quarter surge, transcends the % Revenue growth in the II. Quarter 2022

Within Medical Equipment & Supplies industry 15 other companies have achieved higher Revenue quarter on quarter growth. While Intelligent Bio Solutions Inc 's Revenue growth quarter on quarter, overall rank is 351.


Intelligent Bio Solutions Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 0.93 $ 0.75 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) 23.9 % - - - -
Seq. Revenue Growth (TTM) Overall Ranking # 656 # 0 # 0 # 0 # 0




Cumulative Revenue growth Comment
Intelligent Bio Solutions Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 98.16% year on year, to $ 1 millions if the fiscal year would have ended in Dec 31 2022.
Intelligent Bio Solutions Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Sep 30 2022. And, Intelligent Bio Solutions Inc realized the fastest Revenue growth, in Medical Equipment & Supplies industry.
But sequential growth rate was less at 23.9 % from $0.75 millions achieved in twelve months ending a quarter Sep 30 2022 Ŕlex Navarro went on.
In spite of, this was evidence of convincing trend, while the average sequential Revenue gain stands at 0%.

Intelligent Bio Solutions Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 26
Sector # 100
S&P 500 # 656
Cumulative Revenue growth Comment
Intelligent Bio Solutions Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 98.16% year on year, to $ 1 millions if the fiscal year would have ended in Dec 31 2022.
Intelligent Bio Solutions Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Sep 30 2022. And, Intelligent Bio Solutions Inc realized the fastest Revenue growth, in Medical Equipment & Supplies industry.
But from the previous reporting period growth rate was beneth at 23.9 % from $0.75 millions recorded in twelve months ending a quarter before.
In spite of, this was confirmation of strength, while the average sequential Revenue advancement stands at 0%.
The progress was much stronger from twelve months ended Sep 30 2022 exhibited at 23.9 % increase from $0.75 millions in twelve months ending a quarter before.

Intelligent Bio Solutions Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 26
Sector # 100
S&P 500 # 656




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
INBS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for INBS's Competitors
Revenue Growth for Intelligent Bio Solutions Inc 's Suppliers
Revenue Growth for INBS's Customers

You may also want to know
INBS's Annual Growth Rates INBS's Profitability Ratios INBS's Asset Turnover Ratio INBS's Dividend Growth
INBS's Roe INBS's Valuation Ratios INBS's Financial Strength Ratios INBS's Dividend Payout Ratio
INBS's Roa INBS's Inventory Turnover Ratio INBS's Growth Rates INBS's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2022
Marker Therapeutics inc 166.50%$ 166.499 millions
Agile Therapeutics Inc164.04%$ 164.045 millions
Fate Therapeutics Inc 159.89%$ 159.893 millions
Castle Biosciences Inc 155.42%$ 155.418 millions
Rigel Pharmaceuticals Inc151.25%$ 151.252 millions
Repare Therapeutics Inc 144.82%$ 144.816 millions
Paratek Pharmaceuticals Inc 137.63%$ 137.631 millions
Lumos Pharma Inc 132.73%$ 132.727 millions
Arrowhead Pharmaceuticals Inc 127.95%$ 127.946 millions
Evoke Pharma Inc 120.86%$ 120.864 millions
Rayont Inc 110.48%$ 110.484 millions
Hookipa Pharma inc 109.92%$ 109.922 millions
Viewray Inc 108.85%$ 108.851 millions
Fibrogen Inc 107.74%$ 107.737 millions
Lantheus Holdings Inc 103.12%$ 103.120 millions
Intelligent Bio Solutions Inc 100.62%$ 100.617 millions
Renalytix Plc99.20%$ 99.195 millions
Hims and Hers Health Inc 97.41%$ 97.408 millions
Arbutus Biopharma Corp94.79%$ 94.791 millions
Orasure Technologies Inc93.62%$ 93.616 millions
Revance Therapeutics Inc 92.37%$ 92.374 millions
Adma Biologics Inc 89.45%$ 89.447 millions
Myovant Sciences Ltd 84.11%$ 84.109 millions
Uniqure N v 78.10%$ 78.095 millions
Beigene ltd 77.63%$ 77.632 millions
G1 Therapeutics Inc 76.85%$ 76.846 millions
Inspire Medical Systems inc 75.90%$ 75.897 millions
Sage Therapeutics Inc 74.42%$ 74.421 millions
Arvinas Inc 73.18%$ 73.177 millions
Electrocore Inc 71.72%$ 71.721 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GOVX's Profile

Stock Price

GOVX's Financials

Business Description

Fundamentals

Charts & Quotes

GOVX's News

Suppliers

GOVX's Competitors

Customers & Markets

Economic Indicators

GOVX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071